Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and betacell dysfunction

Details for Australian Patent Application No. 2009243749 (hide)

Owner MERCK PATENT GMBH

Inventors Betz, Ulrich; Scholz, Wolfgang; Braendle, Marian; Beier, Norbert

Agent Griffith Hack

Pub. Number AU-A-2009243749

PCT Pub. Number WO2009/135583

Priority 08008763.8 09.05.08 EP

Filing date 11 April 2009

Wipo publication date 12 November 2009

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/135583 Priority application(s): WO2009/135583

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009243756-Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

2009243740-Wave power plant and method for operating the same